Discover the complete record of transactions filed by Galindo Alejandro, Directeur Commercial. Insider active across 2 companies, notably Mannkind CORP. Cumulatively, 14 disclosures have been logged. Total volume traded: €138k. The latest transaction was disclosed on 18 May 2022 — I. Regulator: SEC (Form 4). All data is accessible without signup.
Alejandro Galindo is the Chief Commercial Officer and EVP of the Endocrine Business Unit at MannKind Corp. In this role, he is responsible for the company's commercial strategy and operations, contributing to its development and growth. His expertise in the commercial field is essential for achieving the company's objectives.